The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksColefax Grp. Regulatory News (CFX)

Share Price Information for Colefax Grp. (CFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 805.00
Bid: 770.00
Ask: 840.00
Change: 0.00 (0.00%)
Spread: 70.00 (9.091%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 805.00
CFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Share Buyback Programme

23 Sep 2022 07:00

RNS Number : 3775A
Colefax Group PLC
23 September 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM THE UNITED STATES OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. 

COLEFAX GROUP PLC

("Colefax" or the "Company")

Launch of Share Buyback Programme

 

The Company today announces that it will commence a share buyback programme to purchase ordinary shares of 10.0 pence each in the Company ("Ordinary Shares") for up to a maximum consideration of £5,355,000 (the "Buyback").

 

The Company has for a number of years followed a policy of buying back Ordinary Shares when they have become available in order to enhance earnings for the remaining shareholders. Pursuant to this policy, the Company has previously launched a number of tender offers to buy back Ordinary Shares, the most recent being in August 2021. Due to low shareholder participation in the last tender offer, the Company's directors have decided to launch the current Buyback, which will give shareholders the ability to sell their shares without the costs involved in a formal tender offer.

 

The Company has entered into a non-discretionary agreement with Peel Hunt LLP ("Peel Hunt") in relation to the purchase by Peel Hunt, acting as "riskless" or "matched" principal, of up to a maximum of 700,000 Ordinary Shares at a price of up to £7.65 per Ordinary Share (the "Purchase Price"), being the closing bid price on 22 September 2022, representing a discount of 3.2 per cent to the closing mid market price on that day. 

 

The primary purpose of the Buyback is to reduce the share capital of the Company. The Ordinary Shares purchased under the Buyback will be cancelled.

 

The directors of the Company consider the Buyback to be in the best interests of the Company and of its shareholders generally, with the implementation of the Buyback expected to enhance earnings per share.

 

Purchases of the Company's Ordinary Shares pursuant to the Buyback will commence immediately and will end no later than 28 September 2022.

 

Any purchase of Ordinary Shares under the Buyback will be carried out on the London Stock Exchange

and will be effected within certain pre-set parameters. In particular, the maximum price which may be paid for an Ordinary Share pursuant to the Buyback is an amount equal to 105% of the average of the middle market quotations for an Ordinary Share as derived from The London Stock Exchange Daily Official List for the five business days immediately preceding the day on which that Ordinary Share is purchased. 

 

Any purchases under the Buyback shall take place in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at the annual general meeting on 23 September 2021 (the "2021 Authority"). Details of the share buyback authority can be found on page 57 of the 2021 Annual Report which can be viewed on the Company's website at colefaxgroupplc.com. The maximum number of Ordinary Shares that the Company is authorised to purchase under the 2021 Authority is 1,190,630.

 

The Buyback will take place in accordance with the Market Abuse Regulation (EU) No. 596/2014 (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019) and the Commission Delegated Regulation (EU) No. 2016/1052 (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019), save that, due to the illiquidity of the Ordinary Shares, more than 25% of the average daily volume of the Ordinary Shares may be purchased in any trading day. The Buyback will be discontinued in the event the Company ceases to have the necessary general authority to repurchase Ordinary Shares.

 

The Company will make further regulatory announcements to shareholders in respect of purchases of

Ordinary Shares under the Buyback no later than 7.30 a.m. on the business day following the calendar day on which the purchase occurred.

 

The person responsible for arranging the release of this announcement on behalf of the Company is

Robert Barker, the Group Finance Director and Company Secretary.

 

Enquiries:

 

Colefax Group plc

David Green, Chief Executive

Rob Barker, Finance Director

 

+44 (0)20 7318 6000

Peel Hunt LLP (NOMAD and broker)

Adrian Trimmings

Andrew Clark

Lalit Bose

 

+44 (0)20 7418 8900

KTZ Communications

Katie Tzouliadis

Dan Mahoney

 

+44 (0)20 3178 6378

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCLTMPTMTJTBIT
Date   Source Headline
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSInterim Results
2nd Oct 20235:41 pmRNSHolding(s) in Company
28th Sep 20232:59 pmRNSResult of AGM
28th Sep 20237:00 amRNSAGM Statement
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSResult of Tender Offer
1st Sep 20237:00 amRNSTender Offer
23rd Jan 20237:00 amRNSInterim Results
20th Dec 20223:27 pmRNSHolding(s) in Company
19th Oct 20225:21 pmRNSDirector/PDMR Shareholding
5th Oct 20224:55 pmRNSHolding(s) in Company
29th Sep 20223:22 pmRNSResult of AGM
29th Sep 20222:46 pmRNSHolding(s) in Company
29th Sep 20227:00 amRNSAGM Statement
26th Sep 20223:54 pmRNSHolding(s) in Company
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20227:00 amRNSLaunch of Share Buyback Programme
23rd Sep 20227:00 amRNSLaunch of Share Buyback Programme
17th Aug 20227:00 amRNSPreliminary Results
21st Apr 20227:00 amRNSTrading Update
27th Jan 20227:00 amRNSInterim Results
23rd Sep 20212:49 pmRNSResult of AGM
23rd Sep 20217:00 amRNSAGM Statement
16th Sep 20212:57 pmRNSDirector/PDMR Share Dealings
14th Sep 20217:00 amRNSResult of Tender Offer
20th Aug 20217:00 amRNSAnnouncement of Tender Offer & Posting of Circular
12th Aug 20217:00 amRNSPreliminary Results
26th Apr 202112:39 pmRNSDirector/PDMR Shareholding
16th Mar 20215:49 pmRNSDirector/PDMR Shareholding
27th Jan 20217:00 amRNSInterim Results
19th Oct 20205:17 pmRNSResult of AGM
19th Oct 20207:00 amRNSAGM Statement
14th Sep 20207:00 amRNSFinal Results
23rd Mar 20207:00 amRNSCOVID-19 Impact and Interim Dividend Cancellation
25th Feb 20202:55 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSInterim Results
18th Sep 20192:14 pmRNSResult of AGM
18th Sep 20197:00 amRNSAGM Statement
23rd Jul 20197:00 amRNSPreliminary Results
7th May 20195:45 pmRNSHolding(s) in Company
1st May 20195:01 pmRNSDirector/PDMR Shareholding
30th Apr 201911:48 amRNSHolding(s) in Company
26th Apr 20197:00 amRNSResult of Tender Offer
9th Apr 20197:00 amRNSTender Offer
29th Jan 20197:00 amRNSHalf Year Results
13th Sep 20183:59 pmRNSResult of AGM
13th Sep 20187:00 amRNSAGM Statement
26th Jul 20187:00 amRNSPreliminary Results
9th Feb 20184:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.